JPWO2022256565A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022256565A5 JPWO2022256565A5 JP2023574349A JP2023574349A JPWO2022256565A5 JP WO2022256565 A5 JPWO2022256565 A5 JP WO2022256565A5 JP 2023574349 A JP2023574349 A JP 2023574349A JP 2023574349 A JP2023574349 A JP 2023574349A JP WO2022256565 A5 JPWO2022256565 A5 JP WO2022256565A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- item
- ribonucleoside
- represented
- internucleoside linkage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163195993P | 2021-06-02 | 2021-06-02 | |
| US63/195,993 | 2021-06-02 | ||
| PCT/US2022/032014 WO2022256565A2 (en) | 2021-06-02 | 2022-06-02 | Compositions and methods for delivering therapeutic oligonucleotides to the central nervous system |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024521897A JP2024521897A (ja) | 2024-06-04 |
| JP2024521897A5 JP2024521897A5 (https=) | 2025-05-28 |
| JPWO2022256565A5 true JPWO2022256565A5 (https=) | 2025-05-28 |
Family
ID=84324589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023574349A Pending JP2024521897A (ja) | 2021-06-02 | 2022-06-02 | 治療用オリゴヌクレオチドを中枢神経系に送達するための組成物及び方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240287526A1 (https=) |
| EP (1) | EP4346845A2 (https=) |
| JP (1) | JP2024521897A (https=) |
| KR (1) | KR20240038930A (https=) |
| CN (1) | CN117795069A (https=) |
| AU (1) | AU2022286420A1 (https=) |
| CA (1) | CA3222212A1 (https=) |
| IL (1) | IL308994A (https=) |
| WO (1) | WO2022256565A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL319764A (en) * | 2022-09-28 | 2025-05-01 | Atalanta Therapeutics Inc | Compositions and methods for treating Huntington's disease |
| WO2024169770A1 (zh) * | 2023-02-17 | 2024-08-22 | 苏州时安生物技术有限公司 | 一种抑制SCN9A基因表达的siRNA、其药物组合物及用途 |
| JP2026509929A (ja) * | 2023-03-23 | 2026-03-25 | アタランタ セラピューティクス，インコーポレーテッド | 改善された遺伝子サイレンシングのための組成物及び方法 |
| WO2025111497A1 (en) * | 2023-11-21 | 2025-05-30 | Ionis Pharmaceuticals, Inc. | Compounds and methods for modulating acute activation |
| WO2025193786A1 (en) * | 2024-03-12 | 2025-09-18 | University Of Massachusetts | Oligonucleotides for prnp modulation |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015125147A1 (en) * | 2014-02-20 | 2015-08-27 | B. G. Negev Technologies And Applications Ltd | Anionic polyplexes for use in the delivery of nucleic acids |
| WO2019122279A1 (en) * | 2017-12-22 | 2019-06-27 | Roche Innovation Center Copenhagen A/S | Oligonucleotides comprising a phosphorodithioate internucleoside linkage |
-
2022
- 2022-06-02 JP JP2023574349A patent/JP2024521897A/ja active Pending
- 2022-06-02 US US18/566,983 patent/US20240287526A1/en active Pending
- 2022-06-02 EP EP22816877.9A patent/EP4346845A2/en active Pending
- 2022-06-02 IL IL308994A patent/IL308994A/en unknown
- 2022-06-02 KR KR1020237045431A patent/KR20240038930A/ko active Pending
- 2022-06-02 CN CN202280052900.3A patent/CN117795069A/zh active Pending
- 2022-06-02 WO PCT/US2022/032014 patent/WO2022256565A2/en not_active Ceased
- 2022-06-02 AU AU2022286420A patent/AU2022286420A1/en active Pending
- 2022-06-02 CA CA3222212A patent/CA3222212A1/en active Pending